Smith & Nephew

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Smith & Nephew and other ETFs, options, and stocks.

About SNN

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. 

CEO
Deepak S Nath
CEODeepak S Nath
Employees
18,362
Employees18,362
Headquarters
Watford, Herefordshire
HeadquartersWatford, Herefordshire
Founded
1856
Founded1856
Employees
18,362
Employees18,362

SNN Key Statistics

Market cap
11.02B
Market cap11.02B
Price-Earnings ratio
17.94
Price-Earnings ratio17.94
Dividend yield
2.83%
Dividend yield2.83%
Average volume
1.25M
Average volume1.25M
High today
$26.36
High today$26.36
Low today
$26.12
Low today$26.12
Open price
$26.31
Open price$26.31
Volume
221.19K
Volume221.19K
52 Week high
$37.51
52 Week high$37.51
52 Week low
$26.12
52 Week low$26.12

SNN News

TipRanks 1d
Smith & Nephew removed from European Conviction List at Goldman Sachs

Goldman Sachs analysts removed Smith & Nephew from the firm’s European Conviction List as part of its monthly update. Published first on TheFly – the ultimate...

Zacks 2d
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research

...

Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care - Zacks Investment Research

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.